Dr. Marra Francis Joins Genece Health as Chief Medical Officer
DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, b...
Source: businessinsider.com
Exai Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Exai Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Exai Bio Today - Breaking & Trending Today
Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028
/PRNewswire/ -- DelveInsight's Liquid Biopsy in Cancer Diagnostics Market Insights report provides the current and forecast market analysis, individual leading...
Source: prnewswire.com
Exai Bio's RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches | Region
PALO ALTO, Calif.--(BUSINESS WIRE)--Dec 6, 2023--
Source: eagletribune.com
Section 32 Closes $525M Fund 5
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Section 32 closes on $525M fund, says there is 'a zone of commoditization that you have to avoid while investing in AI'
Section 32, a venture firm founded by ex-Google Ventures CEO Bill Maris, has closed on $525 million in capital commitments across its fifth fund, TechCrunch is first to report. A portion of the capital will go toward early-stage investments, while the remaining will be reserved for follow-on opportunities. The Palo Alto, California, firm, which now has $2.3 billion in assets under management, has seen a number of notable exits over its six-year history.
Source: yahoo.com